COVID-19 with Different Severities: A Multicenter Study of Clinical Features
暂无分享,去创建一个
Xin Li | Min Zhou | Jian Li | Dexiang Yang | Huihuang Lin | Yong Li | Hongzhou Lu | J. Qu | Hongzhou Lu | T. Bai | Y. Ling | W. Xiong | Jieming Qu | Yun Ling | Tao Bai | Yun Feng | Yusang Xie | Jie Huang | Weining Xiong | Rong Chen | Fangying Lu | Yunfei Lu | Xuhui Liu | Yuqing Chen | Hanssa Dwarka Summah | Jiayang Yan | Xuhui Liu | Hui-huang Lin | Yun Feng | Yuqing Chen | Yunfei Lu | H. Summah | Jiayan Yan | Dexiang Yang | Min Zhou | Jian Li | Fangying Lu | Yong Li | Jie Huang | Rong Chen | Yusang Xie | Xin Li
[1] Fang Li,et al. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor , 2009, Proceedings of the National Academy of Sciences.
[2] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[3] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[4] D. Diz,et al. Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2 , 2005, Circulation.
[5] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[6] J. Farrar,et al. The Radiologic Manifestations of H5N1 Avian Influenza , 2006, Journal of thoracic imaging.
[7] Ping Chen,et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission , 2020, Science China Life Sciences.
[8] Z. Li,et al. Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS† , 2006, The Journal of pathology.
[9] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[10] F. Zhou,et al. Mortality prediction to hospitalized patients with influenza pneumonia: PO2/FiO2 combined lymphocyte count is the answer , 2015, The clinical respiratory journal.
[11] M. Niederman,et al. Rising to the Challenge of COVID-19: Advice for Pulmonary and Critical Care and an Agenda for Research , 2020, American journal of respiratory and critical care medicine.
[12] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[13] Ralph S. Baric,et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.
[14] J. Rello,et al. Severity assessment tools in ICU patients with 2009 influenza A (H1N1) pneumonia. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[16] Wei Cui,et al. Expression of Lymphocytes and Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] Suxin Wan,et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) , 2020, medRxiv.
[18] J. Sung,et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis , 2003, BMJ : British Medical Journal.
[19] C. Eastin,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.
[20] Dong Wei,et al. Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score , 2019, Front. Microbiol..
[21] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[22] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[23] G. Sutter,et al. CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice , 2018, Viruses.
[24] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[25] Jincun Zhao,et al. Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection , 2014, Journal of Virology.
[26] J. Xie,et al. Significant Changes of Peripheral T Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome , 2004, The Journal of infectious diseases.
[27] J. Kuhn,et al. The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2 , 2007, Virology.